Novo Nordisk settles securities lawsuit in Denmark
![Photo: Niels Hougaard/ERH](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13643600.ece/ALTERNATES/schema-16_9/doc7ja2qn0sn2xqoyhxdrf.jpg)
Danish pharmaceutical firm Novo Nordisk has settled a 2019 lawsuit concerning an allegation that shareholders had been misled about insulin sales in the US, the company announces in a press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Eli Lilly sues HHS in strife over discounted drugs
For subscribers